Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-25 @ 3:24 AM
Ignite Modification Date:
2025-12-25 @ 3:24 AM
NCT ID:
NCT05987605
Brief Title:
Phase I/II Clinical Study of 1A46 Drug Substance
Official Title:
A Phase I/II, First in Human, Single Arm, Open Label Study to Evaluate the Safety and Efficacy of the Injection of Triple-specific T-cell Engager 1A46in Adult Subjects with R/R CD20 Positive And/or CD19 Positive B Cell Non-Hodgkin's Lymphoma (B - NHL)
Study:
NCT05987605
Protocol Section:
NCT05987605